Switzerland, BG Group European Headquarters.

Carl Müller is known for his strong-willed tactics and impeccable strategies, but he was deep in anxiety at this moment, with not a single good news lately.

On his desk, there were scattered printouts of experimental data, flowcharts, and analysis reports. This intelligence had been obtained at a huge expense through carefully placed insiders from the Sanbo Research Institute. It concerns Yang Ping's latest breakthrough technology—the core intelligence on the synergetic effects of the "X-2 Enhancer" with a new type of vaccine.

According to Carl's original plan, once the key data was obtained, BG's top laboratories would quickly replicate it successfully and utilize their global patent network to submit priority patent filings before Yang Ping's team could complete comprehensive international patent applications. This had been a tried-and-true legal exploitation tactic they had employed for hundreds of years. With BG's vast team of lawyers and good relations with patent offices worldwide, there was a high probability they could distort and break down Yang Ping's core innovation, finally incorporating it into their own patent fortress or, at the least, set up heavy obstacles, making it extremely difficult for Yang Ping's team to commercialize in the future or even kill it in infancy.

Sometimes, competition is despicable. However, this time he miscalculated, as the opponent's precision clearly exceeded his expectations.

"Mr. Müller," a slightly weary voice broke the silence. It was Dr. Walker speaking, a senior scientist of BG Group, with graying hair and thick glasses, his face filled with confusion and frustration. "We might be in big trouble."

Carl slowly turned around, his gaze sharp like a hawk, his voice deep and steady, but those familiar with him could hear his suppressed anger: "Dr. Walker, the term 'big trouble' shouldn't be in your vocabulary. What I want are solutions, not problem descriptions."

Dr. Walker picked up a document from the desk: "We conducted three independent repeat experiments strictly following the acquired procedures. Although we encountered some difficulties in the initial vector construction and antigen selection, we barely overcame them owing to our technical reserves. The issue arose in the preliminary synthesis of the most critical X-2 Enhancer during the combination and enhancement stage."

He pointed to a series of complex data: "Look here, according to the procedure we need to complete gene recombination at a specific temperature and buffer solution environment. The steps are written clearly, and the reagent ratios seem quite clear. However, when we performed the operation, the reaction system was extremely unstable, either resulting in gene recombination failure, failing to produce the expected immune enhancement signal or directly causing antigen inactivation. In one instance, there was even an uncontrollable polymerization phenomenon, destroying two weeks' worth of work."

Carl moved to the desk, placing both hands on the desktop, leaning forward, emanating strong pressure: "Reasons? Is it that our operations aren't precise enough? Or the equipment isn't accurate enough? BG has the world's leading laboratory conditions; I don't believe we can't achieve what the Chinese can achieve."

"The problem is exactly that!" Dr. Walker raised his head somewhat excitedly, "I suspect the procedure we acquired is inherently incomplete, or encrypted."

"Encrypted?" Carl furrowed his brow tightly.

"Yes, encrypted," Dr. Walker affirmed, "What Yang Ping disclosed is merely a user-friendly manual, telling you what to do without explaining why. Each step relies on underlying principles of physics, chemistry, and biology, key catalytic mechanisms, and permissible error ranges and control parameters, all deliberately hidden. These critical technologies might only apply to his unique tools."

He picked up another report and handed it to Carl: "Even more tricky, this procedure imposes nearly stringent requirements on experimental equipment and reagents. Many critical steps depend on instruments exclusively supplied by a few core enterprises within the Wall-breaking Alliance, and their control software, sensor precision, and even the reactor's inner lining might contain undisclosed technical details. There are also several essential buffers and catalysts; the suppliers of gene combination technology are strictly blocked from us. We attempted to substitute with the closest available market products, but none succeeded, instead introducing new interfering variables."

"Are you saying we can't achieve this with our more precise instruments? That they can achieve it with inferior instruments; is that what you mean?" Carl was quite angry.

Dr. Walker, also provoked by Carl's anger, nodded unyieldingly: "Yes, exactly. In this experiment, our so-called more precise instruments have no advantage and are even a disadvantage."

"Are you joking with me?" Carl stared at Dr. Walker.

The Doctor, undaunted, retorted: "Do I look like I'm joking?"

"How do you explain this?" Carl couldn't believe Walker's words.

The Doctor replied with a hint of sarcasm: "The reasoning is simple; in off-road conditions, a Porsche sports car can't outperform an off-road vehicle worth a few ten thousand US dollars; its so-called various advantages are all disadvantages at this moment."

Carl slumped back into his chair.

Dr. Walker candidly declared: "Mr. Müller, if I may speak frankly, with the current intelligence we have, fully replicating Yang Ping's results would not only require astronomical funds to reverse-engineer those specific devices and reagents, but more importantly, we lack the most core theoretical foundation. If any deviation occurs during the experiment, we don't have the capacity to diagnose the problem or adjust parameters, and deviation in complex biological experiments is nearly inevitable. Yang Ping's team has given us a car without an engine schematic; we might copy the exterior, but we can never get it to run, and it might even explode when we try to start it."

Next chapter will be updated first on this website. Come back and continue reading tomorrow, everyone!

If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.